211 related articles for article (PubMed ID: 19321434)
21. Plasma membrane proteomics of human breast cancer cell lines identifies potential targets for breast cancer diagnosis and treatment.
Ziegler YS; Moresco JJ; Tu PG; Yates JR; Nardulli AM
PLoS One; 2014; 9(7):e102341. PubMed ID: 25029196
[TBL] [Abstract][Full Text] [Related]
22. Identification of key players for colorectal cancer metastasis by iTRAQ quantitative proteomics profiling of isogenic SW480 and SW620 cell lines.
Ghosh D; Yu H; Tan XF; Lim TK; Zubaidah RM; Tan HT; Chung MC; Lin Q
J Proteome Res; 2011 Oct; 10(10):4373-87. PubMed ID: 21854069
[TBL] [Abstract][Full Text] [Related]
23. A liquid chromatography-tandem mass spectrometry-based targeted proteomics approach for the assessment of transferrin receptor levels in breast cancer.
Yang T; Xu F; Zhao Y; Wang S; Yang M; Chen Y
Proteomics Clin Appl; 2014 Oct; 8(9-10):773-82. PubMed ID: 24659461
[TBL] [Abstract][Full Text] [Related]
24. Differential protein expression profiling by iTRAQ-two-dimensional LC-MS/MS of human bladder cancer EJ138 cells transfected with the metastasis suppressor KiSS-1 gene.
Ruppen I; Grau L; Orenes-Piñero E; Ashman K; Gil M; Algaba F; Bellmunt J; Sánchez-Carbayo M
Mol Cell Proteomics; 2010 Oct; 9(10):2276-91. PubMed ID: 20139371
[TBL] [Abstract][Full Text] [Related]
25. Proteomic analysis of two metabolic proteins with potential to translocate to plasma membrane associated with tumor metastasis development and drug targets.
Xue T; Zhang Y; Zhang L; Yao L; Hu X; Xu LX
J Proteome Res; 2013 Apr; 12(4):1754-63. PubMed ID: 23445495
[TBL] [Abstract][Full Text] [Related]
26. [Analysis of the effects of 17beta-oestradiol and serum deprivation on the contents of proteins in breast cancer cells by isobaric tags for relative and absolute quantification and two-dimensional liquid chromatography-tandem mass spectrometry].
Zhu L; Ni G; Zhang Z; Xu X; Hu X; Li W
Se Pu; 2009 May; 27(3):270-8. PubMed ID: 19803128
[TBL] [Abstract][Full Text] [Related]
27. Role of the focal adhesion protein kindlin-1 in breast cancer growth and lung metastasis.
Sin S; Bonin F; Petit V; Meseure D; Lallemand F; Bièche I; Bellahcène A; Castronovo V; de Wever O; Gespach C; Lidereau R; Driouch K
J Natl Cancer Inst; 2011 Sep; 103(17):1323-37. PubMed ID: 21832234
[TBL] [Abstract][Full Text] [Related]
28. NADH-Cytochrome b5 Reductase 3 Promotes Colonization and Metastasis Formation and Is a Prognostic Marker of Disease-Free and Overall Survival in Estrogen Receptor-Negative Breast Cancer.
Lund RR; Leth-Larsen R; Caterino TD; Terp MG; Nissen J; Lænkholm AV; Jensen ON; Ditzel HJ
Mol Cell Proteomics; 2015 Nov; 14(11):2988-99. PubMed ID: 26351264
[TBL] [Abstract][Full Text] [Related]
29. Expression of ecto-5'-nucleotidase (eN, CD73) in cell lines from various stages of human melanoma.
Sadej R; Spychala J; Skladanowski AC
Melanoma Res; 2006 Jun; 16(3):213-22. PubMed ID: 16718268
[TBL] [Abstract][Full Text] [Related]
30. Identification of differentially secreted biomarkers using LC-MS/MS in isogenic cell lines representing a progression of breast cancer.
Mbeunkui F; Metge BJ; Shevde LA; Pannell LK
J Proteome Res; 2007 Aug; 6(8):2993-3002. PubMed ID: 17608509
[TBL] [Abstract][Full Text] [Related]
31. Identification of a putative protein profile associated with tamoxifen therapy resistance in breast cancer.
Umar A; Kang H; Timmermans AM; Look MP; Meijer-van Gelder ME; den Bakker MA; Jaitly N; Martens JW; Luider TM; Foekens JA; Pasa-Tolić L
Mol Cell Proteomics; 2009 Jun; 8(6):1278-94. PubMed ID: 19329653
[TBL] [Abstract][Full Text] [Related]
32. Proteomic profiling identifies breast tumor metastasis-associated factors in an isogenic model.
Kreunin P; Yoo C; Urquidi V; Lubman DM; Goodison S
Proteomics; 2007 Jan; 7(2):299-312. PubMed ID: 17205601
[TBL] [Abstract][Full Text] [Related]
33. Revealing the Biological Attributes of N-Glycan Isomers in Breast Cancer Brain Metastasis Using Porous Graphitic Carbon (PGC) Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
Peng W; Goli M; Mirzaei P; Mechref Y
J Proteome Res; 2019 Oct; 18(10):3731-3740. PubMed ID: 31430160
[TBL] [Abstract][Full Text] [Related]
34. Translating Proteomic Into Functional Data: An High Mobility Group A1 (HMGA1) Proteomic Signature Has Prognostic Value in Breast Cancer.
Maurizio E; Wiśniewski JR; Ciani Y; Amato A; Arnoldo L; Penzo C; Pegoraro S; Giancotti V; Zambelli A; Piazza S; Manfioletti G; Sgarra R
Mol Cell Proteomics; 2016 Jan; 15(1):109-23. PubMed ID: 26527623
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of transgelin 2 promotes breast cancer metastasis by activating the reactive oxygen species/nuclear factor‑κB signaling pathway.
Yang L; Hong Q; Xu SG; Kuang XY; Di GH; Liu GY; Wu J; Shao ZM; Yu SJ
Mol Med Rep; 2019 Nov; 20(5):4045-4258. PubMed ID: 31485630
[TBL] [Abstract][Full Text] [Related]
36. Two-dimensional electrophoretic comparison of metastatic and non-metastatic human breast tumors using in vitro cultured epithelial cells derived from the cancer tissues.
Vydra J; Selicharová I; Smutná K; Sanda M; Matousková E; Bursíková E; Prchalová M; Velenská Z; Coufal D; Jirácek J
BMC Cancer; 2008 Apr; 8():107. PubMed ID: 18416831
[TBL] [Abstract][Full Text] [Related]
37. A proteomics study on human breast cancer cell lines by fluorogenic derivatization-liquid chromatography/tandem mass spectrometry.
Imai K; Ichibangase T; Saitoh R; Hoshikawa Y
Biomed Chromatogr; 2008 Nov; 22(11):1304-14. PubMed ID: 18821527
[TBL] [Abstract][Full Text] [Related]
38. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
[TBL] [Abstract][Full Text] [Related]
39. A liquid chromatography-tandem mass spectrometry-based targeted proteomics assay for monitoring P-glycoprotein levels in human breast tissue.
Yang T; Chen F; Xu F; Wang F; Xu Q; Chen Y
Clin Chim Acta; 2014 Sep; 436():283-9. PubMed ID: 24972002
[TBL] [Abstract][Full Text] [Related]
40. Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis.
Cai D; Cao J; Li Z; Zheng X; Yao Y; Li W; Yuan Z
BMC Cancer; 2009 Apr; 9():102. PubMed ID: 19338666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
